BITSCOPIC published a study highlighting a critical gap in early measles detection where rRT-PCR tests can detect measles before rash onset, but early testing (>4 days before rash) carries lower sensitivity and potential for false negatives.
Published
Signal category
Research & Knowledge
Quote
“A recent study highlights a critical gap in early measles detection: rRT-PCR tests can detect measles before rash onset, but early testing (>4 days before rash) carries a lower sensitivity and potential for false negatives.”
— BITSCOPIC team
Company
BITSCOPIC
Clinical Surveillance | Infection Prevention | Pharmacogenomics | Precision Medicine | Healthcare Analytics
- Industry
- Hospitals and Health Care
- Location
- Palo Alto, US
- Company size
- 34 employees
Bitscopic is a healthcare technology company delivering decision-ready data to support clinical, operational, and research excellence. Our interoperable solutions help health systems turn complex data into clear, actionable insights that improve outcomes and accelerate innovation. With a decade of experience in federal and commercial health, we’re trusted by the people making the most important decisions in healthcare.
Founded 2012